Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

ABEO – abeona therapeutics inc. (US:NASDAQ)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ABEO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/31
09:22 am
abeo
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low Report
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Report
12/31
07:30 am
abeo
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low Report
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Report
12/15
08:17 am
abeo
Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer [Yahoo! Finance]
Medium Report
Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer [Yahoo! Finance]
Report
12/15
07:30 am
abeo
Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer
Medium Report
Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer
Report
12/11
07:30 am
abeo
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas
Low Report
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas
Report
12/8
07:30 am
abeo
Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy
Medium Report
Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy
Report
12/1
07:48 am
abeo
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium Report
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Report
12/1
07:30 am
abeo
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium Report
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Report
11/12
02:58 pm
abeo
Abeona Therapeutics Q3 2025: Strong Financials And Zevaskyn Launch Ahead [Seeking Alpha]
Low Report
Abeona Therapeutics Q3 2025: Strong Financials And Zevaskyn Launch Ahead [Seeking Alpha]
Report
11/12
08:21 am
abeo
Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates [Yahoo! Finance]
Low Report
Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates [Yahoo! Finance]
Report
11/12
07:54 am
abeo
Abeona Therapeutics GAAP EPS of -$0.10 beats by $0.18 [Seeking Alpha]
High Report
Abeona Therapeutics GAAP EPS of -$0.10 beats by $0.18 [Seeking Alpha]
Report
11/12
07:30 am
abeo
Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates
High Report
Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates
Report
11/10
09:54 am
abeo
Abeona Therapeutics: ZEVASKYN Data Key In Gauging Momentum - Why I Hold [Seeking Alpha]
Low Report
Abeona Therapeutics: ZEVASKYN Data Key In Gauging Momentum - Why I Hold [Seeking Alpha]
Report
11/7
07:57 am
abeo
Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation [Yahoo! Finance]
Low Report
Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation [Yahoo! Finance]
Report
11/7
07:30 am
abeo
Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation
Neutral Report
Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation
Report
11/3
07:30 am
abeo
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low Report
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Report
10/30
10:45 am
abeo
Abeona Therapeutics® Announces Permanent J-Code for ZEVASKYN® (prademagene zamikeracel)
Low Report
Abeona Therapeutics® Announces Permanent J-Code for ZEVASKYN® (prademagene zamikeracel)
Report
10/20
08:30 am
abeo
Abeona Therapeutics® Appoints James A. Gow, MD, MBA, MS, MHCM, as Senior Vice President, Head of Clinical Development & Medical Affairs
Low Report
Abeona Therapeutics® Appoints James A. Gow, MD, MBA, MS, MHCM, as Senior Vice President, Head of Clinical Development & Medical Affairs
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2026, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0